Literature DB >> 23677446

Histogenesis and prognostic value of myenteric spread in colorectal cancer: a Japanese multi-institutional study.

Hideki Ueno1, Kazuo Shirouzu, Hideyuki Shimazaki, Hiroshi Kawachi, Yoshinobu Eishi, Yoichi Ajioka, Kiyotaka Okuno, Kazutaka Yamada, Toshihiko Sato, Takaya Kusumi, Ryoji Kushima, Masahiro Ikegami, Motohiro Kojima, Atsushi Ochiai, Akihiko Murata, Yoshito Akagi, Takahiro Nakamura, Kenichi Sugihara.   

Abstract

BACKGROUND: The histogenesis of the pattern of cancer spread along Auerbach's plexus (myenteric spread: MS) remains unclear and its prognostic value in colorectal cancer (CRC) has not been thoroughly investigated.
METHODS: Pathology slides of 2845 pT2/pT3/pT4 CRCs stained with hematoxylin-eosin (H&E) were reviewed at 10 institutions. MS was classified into 2 groups depending on whether it was accompanied by the finding of perineural invasion (PN) within the lesion. In addition, immunohistochemical staining (D2-40, S100, CD56, synaptophysin) was performed for serially sectioned specimens from 50 CRCs diagnosed as having PN-negative MS.
RESULTS: MS was observed in 504 patients (17.7 %); 360 patients were classified as having PN-positive MS and 144 as having PN-negative MS. The 5-year disease-free survival rate of patients with MS was lower than that of patients without MS (63.3 vs 82.7 %, P < 0.0001); however, there was no significant difference in survival outcome according to the presence or absence of intralesion PN in MS. Multivariate analysis showed that the prognostic impact of MS was independent of conventional prognosticators including T and N stages, vascular invasion and extramural PN. In all the tumors having PN-negative MS, remnants of neural tissue were identified within or around cancer nests located at the leading edge of MS.
CONCLUSIONS: MS is an important prognostic factor for CRC. This feature is the result of cancer development with replacement of Auerbach's plexus and can be classified as intramural PN. The clinical significance of "Pn1" in the UICC/AJCC TNM classification could be enhanced by individual assessment both intramurally and extramurally.

Entities:  

Mesh:

Year:  2013        PMID: 23677446     DOI: 10.1007/s00535-013-0822-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  15 in total

1.  Criteria for extramural perineural invasion as a prognostic factor in rectal cancer.

Authors:  H Ueno; K Hase; H Mochizuki
Journal:  Br J Surg       Date:  2001-07       Impact factor: 6.939

2.  Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect.

Authors:  Junjie Peng; Weiqi Sheng; Dan Huang; Alan P Venook; Ye Xu; Zuqing Guan; Sanjun Cai
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

3.  THE SPREAD OF CARCINOMA OF THE RECTUM: INVASION OF LYMPHATICS, VEINS AND NERVES.

Authors:  P H Seefeld; J A Bargen
Journal:  Ann Surg       Date:  1943-07       Impact factor: 12.969

4.  Growth pattern in the muscular layer reflects the biological behaviour of colorectal cancer.

Authors:  H Ueno; K Hase; Y Hashiguchi; M Ishiguro; Y Kajiwara; H Shimazaki; H Mochizuki
Journal:  Colorectal Dis       Date:  2008-10-21       Impact factor: 3.788

5.  Prognostic value of neural invasion in rectal carcinoma: a multivariate analysis on 339 patients with curative resection.

Authors:  C Bognel; C Rekacewicz; H Mankarios; J P Pignon; D Elias; P Duvillard; M Prade; M Ducreux; J Kac; P Rougier
Journal:  Eur J Cancer       Date:  1995-06       Impact factor: 9.162

6.  Prognostic value of perineural invasion in patients with stage II colorectal cancer.

Authors:  Jung Wook Huh; Hyeong Rok Kim; Young Jin Kim
Journal:  Ann Surg Oncol       Date:  2010-02-25       Impact factor: 5.344

7.  Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

Authors:  Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren Enker; Philip B Paty; Martin R Weiser; David Klimstra; Leonard Saltz; Bruce D Minsky; W Douglas Wong
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

8.  Predictors of disease-free survival in rectal cancer patients undergoing curative proctectomy.

Authors:  D Stewart; Y Yan; M Mutch; I Kodner; S Hunt; J Lowney; E Birnbaum; T Read; J Fleshman; D Dietz
Journal:  Colorectal Dis       Date:  2008-11       Impact factor: 3.788

Review 9.  Perineural invasion in cancer: a review of the literature.

Authors:  Catherine Liebig; Gustavo Ayala; Jonathan A Wilks; David H Berger; Daniel Albo
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

10.  Identification of patients with high-risk stage II colon cancer for adjuvant therapy.

Authors:  Hak-Mien Quah; Joanne F Chou; Mithat Gonen; Jinru Shia; Deborah Schrag; Ron G Landmann; José G Guillem; Philip B Paty; Larissa K Temple; W Douglas Wong; Martin R Weiser
Journal:  Dis Colon Rectum       Date:  2008-03-06       Impact factor: 4.585

View more
  2 in total

Review 1.  Exploiting unique features of the gut-brain interface to combat gastrointestinal cancer.

Authors:  Alyssa Schledwitz; Guofeng Xie; Jean-Pierre Raufman
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

2.  Colorectal Cancer Cells Adhere to and Migrate Along the Neurons of the Enteric Nervous System.

Authors:  Emilie Duchalais; Christophe Guilluy; Steven Nedellec; Melissa Touvron; Anne Bessard; Yann Touchefeu; Céline Bossard; Hélène Boudin; Guy Louarn; Michel Neunlist; Laurianne Van Landeghem
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.